GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Holdco Nuvo Group DG Ltd (NAS:NUVO) » Definitions » Capital Expenditure

Holdco Nuvo Group DG (Holdco Nuvo Group DG) Capital Expenditure : $-0.04 Mil (TTM As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Holdco Nuvo Group DG Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Holdco Nuvo Group DG's cash flow for capital expenditures for the six months ended in Dec. 2023 was $-0.04 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.04 Mil.


Holdco Nuvo Group DG Capital Expenditure Historical Data

The historical data trend for Holdco Nuvo Group DG's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Holdco Nuvo Group DG Capital Expenditure Chart

Holdco Nuvo Group DG Annual Data
Trend Dec21 Dec22 Dec23
Capital Expenditure
-0.24 -0.25 -0.04

Holdco Nuvo Group DG Semi-Annual Data
Dec21 Dec22 Dec23
Capital Expenditure -0.24 -0.25 -0.04

Holdco Nuvo Group DG Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Holdco Nuvo Group DG (Holdco Nuvo Group DG) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
94 Yigal Alon Street, Alon Tower 1, Tel Aviv, ISR, 6789155
Holdco Nuvo Group DG Ltd is a women's health and connected pregnancy care company and has developed INVU by Nuvo, an FDA-cleared, prescription-initiated, remote pregnancy monitoring platform that enables the delivery of remote non-stress tests and maternal and fetal heart rate monitoring, helping expectant mothers adhere to their prescribed care plan. It is leading the transformation from a world where pregnancy care is limited by outdated technology and barriers to accessing care to a world where data-driven, clinically relevant, actionable insights can be accessed both at home and in the clinic. INVU is composed of a hardware component (wearable), with digital signal processing and cloud analytics, and interfaces for every participant involved in pregnancy care.

Holdco Nuvo Group DG (Holdco Nuvo Group DG) Headlines